Articles Vol. 67 No. 1 15/01/2026

QUALITY OF LIFE IN PATIENTS WITH INTERSTITIAL LUNG DISEASE AT THE NATIONAL LUNG HOSPITAL IN 2024

Nguyen Thi Bich Ngoc1,2, Nguyen Thi Trang1,2, Nguyen Cong Hoang Anh1,2
1 National Lung Hospital
2 Bệnh viện Phổi Trung ương
Corresponding author: NgocN4@hotmail.com
DOI: 10.52163/yhc.v67i1.4160
20 Views
16 Downloads
Keywords
Interstitial lung disease, quality of life, EQ-5D-5L, EQ-VAS.
Abstract

Objectives: To investigate the quality of life of patients with interstitial lung disease at the National Lung Hospital.

Methodology: A cross-sectional descriptive study was conducted on 124 patients diagnosed with interstitial lung disease and treated at the National Lung Hospital from September to December 2024. The assessment tools included the EQ-5D-5L quality of life questionnaire and the VAS.

Results: The age group from 61 to 70 years had the highest proportion (40.3%), while the 30 to 40 years group had the lowest (6.5%). The mean age of the patients was 61.1 years. Female patients were predominant, accounting for 66.1%. Regarding the aspects of quality of life assessed by the EQ-5D-5L: 55.6% of patients were affected in their mobility, 41.1% needed assistance with self-care, 53.2% were affected in their usual activities, 52.4% felt pain/discomfort, and 49.2% experienced anxiety/depression. The patients’ quality of life was reduced, with a mean score of 0.8065. The quality of life scores for the different aspects were directly proportional to the SpO2 index and inversely proportional to the mMRC score.

Conclusion: The quality of life of patients with interstitial lung disease at the National Lung Hospital is reduced, particularly in the physical and mental aspects. This reduction is closely related to respiratory function indicators such as SpO2 and mMRC. The study’s results suggest that early detection and intervention can improve the patients’ quality of life.

References
[1]
Bộ Y tế. Quyết định số1005/QĐ-BYT về việc ban hành tài liệu chuyên môn “Hướng dẫn chẩn đoán và điều trị Bệnh phổi mô kẽ”, ngày 22 tháng 02 năm 2023. Google Scholar
[2]
World Health Organization. Health promotion glossary [Internet]. 1998 [cited 2025 Aug 25]. Available from: https://www.who.int/publications/i/item/WHO-HPR-HEP-98.1 Google Scholar
[3]
Maqhuzu P.N, Szentes B.L, Kreuter M, Bahmer T, Kahn N, Claussen M, et al. Determinants of health-related quality of life decline in interstitial lung disease. Health Qual Life Outcomes, 2020, 18: 334. 10.1186/s12955-020-01569-4. Google Scholar
[4]
Trần Ngọc Anh, Chu Thị Hạnh. Đặc điểm lâm sàng, cận lâm sàng và một số căn nguyên của bệnh phổi mô kẽ. Tạp chí Y học Việt Nam, 2022, 519 (2): 57-60. https://doi.org/10.51298/vmj.v519i2.3615. Google Scholar
[5]
Szentes B.L, Kreuter M, Bahmer T, Birring S.S,Claussen M, Waelscher J et al. Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the Google Scholar
[6]
generic EQ-5D-5L. Respir Res, 2018, 19 (1): 101. 10.1186/s12931-018-0798-5. Google Scholar
[7]
Phua G, Tan G.P, Phua H.P, Lim W.Y, Neo H.Y, Chai G.T. Health-related quality of life in a multiracial Asian interstitial lung disease cohort. J Thorac Dis, 2022, 14 (12): 4713-24. 10.21037/jtd-22-1011. Google Scholar
[8]
Kanjrawi A.A, Mathers L, Webster S, Corte T.J, Carey S.Nutritional status and quality of life in interstitial lung disease: a prospective cohort study. BMC Pulm Med, 2021, 21 (1): 51. 10.1186/s12890-021-01618-3. Google Scholar